<p>/PRNewswire/ -- 安比奥生物科技参加了第 50 届世界小动物兽医协会大会（WSAVA 2025），这是一个国际聚会，汇集了来自 100 多个国家的兽医、研究人员和行业代表。此次活动为安比奥提供了展示其兽医诊断产品组合的平台，并与全球市场的合作伙伴交流观点。</p>
<p>在 WSAVA 2025 上，安比奥展示了五条产品线：</p>
<p>继续阅读</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>安比奥生物科技兽医诊断产品组合</p>
<ul>
<li>荧光免疫测定（FIA）</li>
<li>干化学</li>
<li>分子诊断</li>
<li>胶体金快速检测</li>
<li>干化学发光免疫测定（CLIA）</li>
</ul>
<p>该产品组合引起了兽医、分销商和行业参与者的兴趣。干化学发光和荧光免疫测定系统因其精确性和可用性而受到关注，而与分销商的讨论反映了兽医医疗中对可及和准确检测技术的需求。</p>
<p>一个关键特点是安比奥的分子诊断平台，能够在 15 分钟内产生多靶标实时 PCR 结果。该功能被强调为快速检测动物呼吸道和传染病的实用选择，及时的结果对临床管理至关重要。与会代表指出，这类技术在加强疫情响应和支持常规诊断工作流程中的相关性。</p>
<p>展会还为安比奥提供了与现有和潜在合作伙伴互动的机会，讨论分销策略，并考虑未来产品的推出。这些交流强调了即时诊断在兽医实践中日益重要的角色，并强调了国际合作在扩大诊断工具可及性方面的重要性。</p>
<p>展望未来，安比奥将继续其全球拓展。公司计划参加 2025 年西部兽医展（Wild West Vet Show 2025），该展会将于 2025 年 10 月 15 日至 18 日在美国内华达州雷诺举行。此次展会将为安比奥提供另一个展示其兽医诊断产品组合的机会，并与北美市场的专业人士互动。</p>
<p>安比奥参加 WSAVA 2025 反映了其在人体和兽医诊断方面的持续努力。通过推进实用和可靠的检测解决方案，公司为改善全球各地的医疗保健结果做出了贡献。</p>
<p><strong>关于安比奥生物科技</strong> 安比奥生物科技是一家全球导向的体外诊断（IVD）公司，提供广泛的解决方案，包括免疫荧光、干化学、化学发光、分子诊断、快速检测和兽医诊断。公司在多个地区开展业务，致力于提高可靠和及时的诊断的可用性，支持全球医疗保健环境中的更好决策。</p>
<p>来源：安比奥生物科技</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDA4Jk5ld3NJdGVtSWQ9Q045Mjk4MCZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMDgyMzQxUFJfTkVXU19VU1BSX19fX19DTjkyOTgw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDA4Jk5ld3NJdGVtSWQ9Q045Mjk4MCZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMDgyMzQxUFJfTkVXU19VU1BSX19fX19DTjkyOTgw"/></p>

NNNN

<p>安比奥生物科技在 2025 年第五十届世界兽医协会大会上展示了其兽医诊断产品组合，与全球兽医和行业代表进行了交流。该公司展示了五条产品线，包括能够快速检测传染病的先进分子诊断技术。此次活动突显了兽医医疗中对可及性检测技术日益增长的需求，并强调了国际合作的重要性。安比奥计划在 2025 年西部兽医展上继续拓展其影响力，进一步致力于通过可靠的诊断改善医疗结果</p>

<p>, /PRNewswire/ -- Anbio Biotechnology participated in the 50th World Small Animal Veterinary Association Congress (WSAVA 2025), an international gathering that brought together veterinarians, researchers, and industry representatives from more than 100 countries. The event provided a platform for Anbio to present its veterinary diagnostic portfolio and exchange views with partners across global markets.</p>
<div class="lb-trans"><p>/PRNewswire/ -- 安比奥生物科技参加了第 50 届世界小动物兽医协会大会（WSAVA 2025），这是一个国际聚会，汇集了来自 100 多个国家的兽医、研究人员和行业代表。此次活动为安比奥提供了展示其兽医诊断产品组合的平台，并与全球市场的合作伙伴交流观点。</p>
</div><p>At WSAVA 2025, Anbio displayed five product lines:</p>
<div class="lb-trans"><p>在 WSAVA 2025 上，安比奥展示了五条产品线：</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>继续阅读</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Anbio Biotechnology Veterinary Diagnostic Portfolio</p>
<div class="lb-trans"><p>安比奥生物科技兽医诊断产品组合</p>
</div><ul>
<li>Fluorescence Immunoassay (FIA)</li>
<li>Dry Chemistry</li>
<li>Molecular Diagnostics</li>
<li>Colloidal Gold Rapid Tests</li>
<li>Dry Chemiluminescence Immunoassay (CLIA)</li>
</ul>
<div class="lb-trans"><ul>
<li>荧光免疫测定（FIA）</li>
<li>干化学</li>
<li>分子诊断</li>
<li>胶体金快速检测</li>
<li>干化学发光免疫测定（CLIA）</li>
</ul>
</div><p>The portfolio generated interest among veterinarians, distributors, and industry participants. The dry chemiluminescence and fluorescence immunoassay systems were noted for their precision and usability, while discussions with distributors reflected demand for accessible and accurate testing technologies in veterinary healthcare.</p>
<div class="lb-trans"><p>该产品组合引起了兽医、分销商和行业参与者的兴趣。干化学发光和荧光免疫测定系统因其精确性和可用性而受到关注，而与分销商的讨论反映了兽医医疗中对可及和准确检测技术的需求。</p>
</div><p>A key feature was Anbio's molecular diagnostics platform, capable of producing multi-target real-time PCR results within 15 minutes. This function was highlighted as a practical option for the rapid detection of respiratory and infectious diseases in animals, where timely results are critical to clinical management. Delegates pointed to the relevance of such technologies in strengthening outbreak response and supporting routine diagnostic workflows.</p>
<div class="lb-trans"><p>一个关键特点是安比奥的分子诊断平台，能够在 15 分钟内产生多靶标实时 PCR 结果。该功能被强调为快速检测动物呼吸道和传染病的实用选择，及时的结果对临床管理至关重要。与会代表指出，这类技术在加强疫情响应和支持常规诊断工作流程中的相关性。</p>
</div><p>The exhibition also provided opportunities for Anbio to engage with existing and potential partners, discuss distribution strategies, and consider future product rollouts. These exchanges underlined the increasing role of point-of-care diagnostics in veterinary practice and emphasized the importance of international collaboration in expanding access to diagnostic tools.</p>
<div class="lb-trans"><p>展会还为安比奥提供了与现有和潜在合作伙伴互动的机会，讨论分销策略，并考虑未来产品的推出。这些交流强调了即时诊断在兽医实践中日益重要的角色，并强调了国际合作在扩大诊断工具可及性方面的重要性。</p>
</div><p>Looking ahead, Anbio will continue its global outreach. The company is scheduled to participate in the Wild West Vet Show 2025, taking place from October 15–18, 2025, in Reno, Nevada, USA. The exhibition will provide another opportunity to present its veterinary diagnostic portfolio and to interact with professionals from the North American market.</p>
<div class="lb-trans"><p>展望未来，安比奥将继续其全球拓展。公司计划参加 2025 年西部兽医展（Wild West Vet Show 2025），该展会将于 2025 年 10 月 15 日至 18 日在美国内华达州雷诺举行。此次展会将为安比奥提供另一个展示其兽医诊断产品组合的机会，并与北美市场的专业人士互动。</p>
</div><p>Anbio's participation in WSAVA 2025 reflects its continuing efforts in both human and veterinary diagnostics. By advancing practical and reliable testing solutions, the company contributes to improving healthcare outcomes in diverse settings worldwide.</p>
<div class="lb-trans"><p>安比奥参加 WSAVA 2025 反映了其在人体和兽医诊断方面的持续努力。通过推进实用和可靠的检测解决方案，公司为改善全球各地的医疗保健结果做出了贡献。</p>
</div><p><strong>About Anbio Biotechnology</strong> Anbio Biotechnology is a globally oriented in vitro diagnostics (IVD) company providing a broad range of solutions, including immunofluorescence, dry chemistry, chemiluminescence, molecular diagnostics, rapid testing and veterinary diagnostics. With operations across multiple regions, the company works to enhance the availability of reliable and timely diagnostics, supporting better decision-making in healthcare settings worldwide.</p>
<div class="lb-trans"><p><strong>关于安比奥生物科技</strong> 安比奥生物科技是一家全球导向的体外诊断（IVD）公司，提供广泛的解决方案，包括免疫荧光、干化学、化学发光、分子诊断、快速检测和兽医诊断。公司在多个地区开展业务，致力于提高可靠和及时的诊断的可用性，支持全球医疗保健环境中的更好决策。</p>
</div><p>SOURCE Anbio Biotechnology</p>
<div class="lb-trans"><p>来源：安比奥生物科技</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDA4Jk5ld3NJdGVtSWQ9Q045Mjk4MCZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMDgyMzQxUFJfTkVXU19VU1BSX19fX19DTjkyOTgw" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=CN92980&amp;Transmission_Id=202510082341PR_NEWS_USPR_____CN92980&amp;DateId=20251008"/></p>

推动兽医医疗进步：Anbio 在 WSAVA 2025 上展示其诊断产品组合